Cargando…

Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells

Chronic kidney disease is characterized by Vitamin D deficiency and activation of the renin-angiotensin-aldosterone system. Increasing data show that vitamin D receptor agonists (VDRAs) exert beneficial effects in renal disease and possess anti-inflammatory properties, but the underlying mechanism r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgado-Pascual, Jose L., Rayego-Mateos, Sandra, Valdivielso, Jose M., Ortiz, Alberto, Egido, Jesus, Ruiz-Ortega, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438184/ https://www.ncbi.nlm.nih.gov/pubmed/26064952 http://dx.doi.org/10.1155/2015/783538

Ejemplares similares

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
por: Rayego-Mateos, Sandra, et al.
Publicado: (2018)

CCN2 Binds to Tubular Epithelial Cells in the Kidney
por: Rayego-Mateos, Sandra, et al.
Publicado: (2022)

Gremlin Regulates Tubular Epithelial to Mesenchymal Transition via VEGFR2: Potential Role in Renal Fibrosis
por: Marquez-Exposito, Laura, et al.
Publicado: (2018)

Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
por: Morgado-Pascual, Jose Luis, et al.
Publicado: (2018)

Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases
por: Morgado-Pascual, Jose Luis, et al.
Publicado: (2019)

Bisphenol A Modulates Autophagy and Exacerbates Chronic Kidney Damage in Mice
por: Priego, Alberto Ruiz, et al.
Publicado: (2021)

Paricalcitol Attenuates 4-Hydroxy-2-Hexenal-Induced Inflammation and Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Epithelial Cells
por: Kim, Chang Seong, et al.
Publicado: (2013)

Gremlin Activates the Smad Pathway Linked to Epithelial Mesenchymal Transdifferentiation in Cultured Tubular Epithelial Cells
por: Rodrigues-Diez, Raquel, et al.
Publicado: (2014)

Correction: Paricalcitol Attenuates 4-Hydroxy-2-Hexenal-Induced Inflammation and Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Epithelial Cells
por: Kim, Chang Seong, et al.
Publicado: (2013)

BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease
por: Rayego-Mateos, Sandra, et al.
Publicado: (2023)

TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2
por: Rodrigues-Díez, Raquel, et al.
Publicado: (2015)

Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis
por: Morgado-Pascual, José Luis, et al.
Publicado: (2022)

Aldosterone Induces the Proliferation of Renal Tubular Epithelial Cells In Vivo but Not In Vitro
por: Hao, Juan, et al.
Publicado: (2021)

IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
por: Marchant, Vanessa, et al.
Publicado: (2020)

Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells
por: Magkrioti, Christiana, et al.
Publicado: (2022)

Anti-inflammatory and anti-apoptotic effects of paricalcitol in lipopolysaccharide-induced renal proximal tubular cell injury
por: Kim, Soo Wan
Publicado: (2017)

Proinflammatory cytokines regulate epidermal stem cells in wound epithelialization
por: Xiao, Tong, et al.
Publicado: (2020)

Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics
por: Arenas Jimenez, María Dolores, et al.
Publicado: (2021)

Comparison of the Pharmacological Effects of Paricalcitol and Doxercalciferol on the Factors Involved in Mineral Homeostasis
por: Wu-Wong, J. Ruth, et al.
Publicado: (2010)

NLRP2 Regulates Proinflammatory and Antiapoptotic Responses in Proximal Tubular Epithelial Cells
por: Rossi, Marianna N., et al.
Publicado: (2019)

Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes
por: Marquez-Exposito, Laura, et al.
Publicado: (2021)

Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process
por: Rodrigues Díez, Raúl, et al.
Publicado: (2010)

Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation
por: Lavoz, Carolina, et al.
Publicado: (2012)

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
por: Izquierdo, María Jesús, et al.
Publicado: (2012)

Protective Role of Nrf2 in Renal Disease
por: Guerrero-Hue, Melania, et al.
Publicado: (2020)

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
por: Cruzado, Josep M., et al.
Publicado: (2017)

Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E(2) receptor EP4
por: Hong, Yu Ah, et al.
Publicado: (2017)

A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells
por: Ucero, Álvaro C., et al.
Publicado: (2013)

The Increase in FGF23 Induced by Calcium Is Partially Dependent on Vitamin D Signaling
por: Rayego-Mateos, Sandra, et al.
Publicado: (2022)

Inflammatory and Fibrotic Mediators in Renal Diseases
por: Rayego-Mateos, Sandra, et al.
Publicado: (2019)

Osteoprotegerin in Exosome-Like Vesicles from Human Cultured Tubular Cells and Urine
por: Benito-Martin, Alberto, et al.
Publicado: (2013)

Albumin-induced apoptosis of tubular cells is modulated by BASP1
por: Sanchez-Niño, M D, et al.
Publicado: (2015)

Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia
por: Sanz, Ana B, et al.
Publicado: (2009)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
por: Rayego-Mateos, Sandra, et al.
Publicado: (2020)

Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis
por: Bozic, Milica, et al.
Publicado: (2020)

Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
por: Oliva-Damaso, Elena, et al.
Publicado: (2016)

Paricalcitol Reduces Peritoneal Fibrosis in Mice through the Activation of Regulatory T Cells and Reduction in IL-17 Production
por: González-Mateo, Guadalupe T., et al.
Publicado: (2014)

Statins: Could an old friend help in the fight against COVID‐19?
por: Rodrigues‐Diez, Raul R., et al.
Publicado: (2020)

Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone
por: Leung, Joseph CK, et al.
Publicado: (2011)

Antiapoptotic Effect of Paricalcitol in Gentamicin-induced Kidney Injury
por: Suh, Sang Heon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tnc0uhrk0gnn861na8u1p9g91o